Home » Topics » BioWorld Science, Respiratory

BioWorld Science, Respiratory
RSS

Takeda claims NK1 ligands for respiratory indications

May 17, 1996

PDE IV inhibitor SB-207499 in phase II

May 17, 1996

Byk Gulden reports PDE IV inhibitors for asthma, dermatoses

May 17, 1996

Pentoxifylline claimed for treating cold symptoms

May 17, 1996

R-844: Novel steroid for asthma

May 10, 1996

Glaxo Wellcome's newest approach to ARDS

May 3, 1996

Arris announces preliminary results for APC-366

May 3, 1996

Rupatadine poised to enter phase II

May 3, 1996

New Glaxo Wellcome compounds protect against leukocyte-induced tissue damage

April 26, 1996

TAC-363 pharmacological profile presented

April 26, 1996

Popular Stories

Today's news in brief
BioWorld
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...